APA
RCKT icon

American Portfolios Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

American Portfolios Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$11.2K Hold
700
– – ﹤0.01% 2483
2022
Q2 		$9.63K Buy
700
+500
+250% +$5.96K ﹤0.01% 2586
2022
Q1 		$3.17K Buy
+200
New +$3.46K ﹤0.01% 3093

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American Portfolios Advisors's RCKT Position: Q3 2022 in Review

American Portfolios Advisors held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2022 at 700 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

American Portfolios Advisors first reported a position in RCKT in Q1 2022 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold RCKT as of Q3 2022.

  • American Portfolios Advisors held 700 shares of Rocket Pharmaceuticals worth $11.2K as of Q3 2022.
  • American Portfolios Advisors left its Rocket Pharmaceuticals share count unchanged in Q3 2022.
  • Rocket Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2483 holding.
  • American Portfolios Advisors first reported a position in Rocket Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.